We expect to see more pack trade-offs in potato chips, soft drinks and cold cereal but we also see outsized pack trade-offs in coffee and granola, which implies two emerging trends in the GLP-1 population: a general decrease in snacking, even for snacks usually considered healthy, and overall collateral damage that is spreading to categories that should not be greatly affected by GLP-1 status. In addition to their impact on the retail food and beverage market, oral GLP-1 medications are expected to account for 20% of total GLP-1 drug sales by 2031, with a pill market that is estimated to grow from $3.2 billion in 2025 to $34.3 billion in 2031, according to GlobalData.
We got our, we get ourselves to where we get ourselves
R NAT2 polymorphisms alter catalytic activity primarily through effects on protein stability and degradation rates rather than changes to the active site itself (slow acetylator alleles produce unstable protein that is rapidly ubiquitinated and degraded)
Novo Nordisk provides a savings card program
Click-through RUO acknowledgment with two PDF copies sent to your inbox
Comment: Several commenters disagreed with the proposed work RVU of 19.91 for CPT code 33883 and stated that CMS should finalize the RUC-recommended work RVU of 24.25
